Vuksan, V
Choleva, L
Jovanovski, E
Jenkins, A L
Au-Yeung, F
Dias, A G
Ho, H V T
Zurbau, A
Duvnjak, L
Article History
Received: 22 January 2016
Revised: 14 May 2016
Accepted: 24 June 2016
First Online: 21 December 2016
Competing interests
: V Vuksan acted as a consultant to Salba Corporation, Buena Aires, Argentina (2003–2006), Core Naturals, FL, USA (2007–2008) and received conference travel grants from Salba Smart Natural Products (2008&2010), LLC, Centennial, CO, USA and Source Salba Inc, Toronto, Canada (2008). V Vuksan holds an American (No. 7 326 404 B2) and Canadian (No. 2 410 556) patent for use of viscous fiber blend in diabetes, metabolic syndrome and cholesterol lowering; received a honorarium for scientific advice from InovoBiologic (Calgary, AB, Canada) the producer of viscous fiber blend PGX that is developed based on Vuksan’s patent. V Vuksan was VP and partial owner of Glycemic Index Laboratories (Toronto, ON., Canada) a contract research organization, (2004–2015). A Jenkins is VP and partial owner of Glycemic Index Laboratories (Toronto, ON., Canada) a clinical research organization. All other authors have no conflict of interest to declare.